Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: SVY

Apple Launches New Apple Watch Series with Blood Oxygen Monitoring Capabilities


DUBLIN, Sept. 24, 2020 /PRNewswire/ -- ResearchAndMarkets.com published a new article on the wearable tech industry "Apple announced blood oxygen monitoring, fitness programme"

Research and Markets Logo

At their annual event on 15th September, Apple rolled out a new Apple Watch series that monitors blood oxygen; the technology is designed to aid users monitor the effects of the COVID-19 virus, which lowers blood oxygen to dangerous levels. The move is an attempt to compete with Fitbit, which introduced a way to measure changes in blood oxygen earlier this year.

Apple also introduced a smart fitness service powered by its watches, which can deliver virtual workouts, catering to customers trying to stay in shape during quarantine. The company also rolled its TV, news and fitness into a single smart bundle.

Apple shares have soared this year even as the virus has crippled economies around the world, thanks in large part to booming sales of work-from-home items.

To see the full article and a list of related reports on the market, visit "Apple announced blood oxygen monitoring, fitness programme"

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 17:50
The First Bancshares, Inc. Reports Results for First Quarter ended March 31, 2024
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

at 17:30
Biophytis Announces Transfer of ADSs to OTC Market
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

at 17:10
Teradyne Reports First Quarter 2024 Results
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

at 17:00
Alamos Gold Reports First Quarter 2024 Results
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...

at 16:57
Board Declares Quarterly Dividend; Increases Share Repurchase Authorization and Elects New Officer
Ball Corporation's board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable June 17, 2024, to shareholders of record as of June 3, 2024. In addition, the board also approved the repurchase by the company of up...

at 16:45
New Pandemic Agreement: Pharma Wins, Developing World Loses, says AHF Global Public Health Institute
As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the...

More news about Covid-19 virus...


News published on and distributed by: